Fig. 9From: Autophagy inhibition improves the targeted radionuclide therapy efficacy of 131I-FAP-2286 in pancreatic cancer xenograftsCAFs-targeted 131I-FAP-2286 induces the protective autophagy of pancreatic cancer cells, limiting the therapeutic effect of TRT, and the addition of 3-MA promotes cancer cell apoptosis by inhibiting autophagy (Created with BioRender.com)Back to article page